"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 0 | 3 | 3 |
| 2015 | 1 | 8 | 9 |
| 2016 | 1 | 11 | 12 |
| 2017 | 0 | 4 | 4 |
| 2018 | 0 | 11 | 11 |
| 2019 | 1 | 8 | 9 |
| 2020 | 0 | 14 | 14 |
| 2021 | 2 | 6 | 8 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 4 | 5 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Acid Sphingomyelinase Regulates AdipoRon-Induced Differentiation of Arterial Smooth Muscle Cells via TFEB Activation. Int J Mol Sci. 2025 Feb 27; 26(5).
-
Fibroblast growth factor-inducible 14 regulates satellite cell self-renewal and expansion during skeletal muscle repair. JCI Insight. 2025 Jan 28; 10(5).
-
Regulation of Cancer Metastasis by PAK2. Int J Mol Sci. 2024 Dec 15; 25(24).
-
Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer. Front Endocrinol (Lausanne). 2024; 15:1450648.
-
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature. 2025 Jan; 637(8047):940-946.
-
?1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation. Cardiovasc Res. 2024 Sep 21; 120(11):1279-1294.
-
Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy. J Med Chem. 2024 Apr 11; 67(7):5333-5350.
-
Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-ß Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice. Circ Heart Fail. 2023 Dec; 16(12):e010351.
-
The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with the snRNP biogenesis machinery. Oncogene. 2023 06; 42(22):1821-1831.
-
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer. Sci Rep. 2022 02 04; 12(1):1972.